机械通气撤机筛查频率:两项同期概念验证随机对照试验
两项同期多中心先导随机对照试验(RELEASE和SENIOR)分别在加拿大10个和11个ICU评估频繁筛查对撤机的影响。RELEASE纳入<65岁、SENIOR纳入≥65岁、有创通气至少24小时的危重成人,比较每日一次筛查与由呼吸治疗师主导的至少每日两次筛查。两试验招募率相似(1.32和1.26例/月/ICU),同意率和方案依从性均高(>92%),交叉率低,不良事件少。虽检验效能不足,至少每日两次筛查与成功拔管时间更短(无统计学意义)和更多成功拔管相关,但两试验合并后显著增加无创通气使用。
要点
- 在加拿大10个和11个ICU中,年轻(<65岁)与老年(≥65岁)患者招募率分别为1.32和1.26例/月/ICU,同意率和方案依从性均>92%。
- 至少每日两次筛查相比每日一次筛查,成功拔管时间更短但无统计学意义,成功拔管更多,但两试验合并后显著增加无创通气使用。
- 两试验交叉率低,不良事件少,支持在北美ICU开展单一大型试验评估更频繁筛查的净临床获益。
- 该先导试验检验效能不足,结果为初步探索性,不能据此在床旁常规推荐至少每日两次筛查。
适用人群与场景
- RELEASE试验纳入<65岁、SENIOR试验纳入≥65岁的危重成人,均需要有创机械通气至少24小时。
- 研究在加拿大ICU进行,RELEASE涉及10个ICU,SENIOR涉及11个ICU。
处置流程与药物剂量
- 两试验均比较每日一次筛查与至少每日两次筛查,筛查由呼吸治疗师主导。
研究设计与关键结果
- 两试验共纳入155例患者:RELEASE 53例(每日一次23例,至少每日两次30例),SENIOR 102例(每日一次54例,至少每日两次48例)。
- 两试验招募率相似(1.32和1.26例/月/ICU),同意率和方案依从性均高(>92%),交叉率低,不良事件少。
- 虽检验效能不足,至少每日两次筛查与成功拔管时间更短但无统计学意义、成功拔管更多相关,但两试验合并后显著增加无创通气使用。
证据类型、等级与局限
- 证据类型:两项同期多中心先导随机对照试验(RELEASE和SENIOR)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在北美ICU中,年轻与老年患者相似的招募率、同意率、不良事件和结局支持开展单一大型试验评估更频繁筛查的净临床获益。
- 先导试验结果不足以支持在床旁常规将筛查频率改为至少每日两次;至少每日两次筛查可能增加无创通气使用需在大样本中进一步评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: It is unknown whether more frequent screening of invasively ventilated patients, identifies patients earlier for a spontaneous breathing trial, and shortens the duration of ventilation. We assessed the feasibility of conducting a large trial to evaluate screening frequency in critically ill adults in the North American context.
DESIGN: We conducted two contemporaneous, multicenter, pilot, randomized controlled trials (the LibeRation from MEchanicaL VEntilAtion and ScrEening Frequency [RELEASE] and Screening Elderly PatieNts For InclusiOn in a Weaning [SENIOR] trials) to address concerns regarding the potential for higher enrollment, fewer adverse events, and better outcomes in younger patients.
SETTING: Ten and 11 ICUs in Canada, respectively.
PATIENTS: Parallel trials of younger (RELEASE < 65 yr) and older (SENIOR ≥ 65 yr) critically ill adults invasively ventilated for at least 24 hours.
INTERVENTIONS: Each trial compared once daily screening to "at least twice daily" screening led by respiratory therapists.
MEASUREMENTS AND MAIN RESULTS: In both trials, we evaluated recruitment (aim: 1-2 patients/month/ICU) and consent rates, reasons for trial exclusion, protocol adherence (target: ≥ 80%), crossovers (aim: ≤ 10%), and the effect of the alternative screening frequencies on adverse events and clinical outcomes. We included 155 patients (53 patients [23 once daily, 30 at least twice daily] in RELEASE and 102 patients [54 once daily, 48 at least twice daily] in SENIOR). Between trials, we found similar recruitment rates (1.32 and 1.26 patients/month/ICU) and reasons for trial exclusion, high consent and protocol adherence rates (> 92%), infrequent crossovers, and few adverse events. Although underpowered, at least twice daily screening was associated with a nonsignificantly faster time to successful extubation and more successful extubations but significantly increased use of noninvasive ventilation in both trials combined.
CONCLUSIONS: Similar recruitment and consent rates, few adverse events, and comparable outcomes in younger and older patients support conduct of a single large trial in North American ICUs assessing the net clinical benefits associated with more frequent screening.
参考来源
- Burns KEA, Wong JTY, Dodek P, et al. Frequency of Screening for Weaning From Mechanical Ventilation: Two Contemporaneous Proof-of-Principle Randomized Controlled Trials. Crit Care Med. 2019. PMID: 30920411. doi:10.1097/CCM.0000000000003722
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。